Insiders · SANA

Douglas E Williams

EVP & President, R&D at Sana Biotechnology, Inc. (SANA) since April 2023

Douglas E Williams has filed 20 insider reports with the SEC since January 2021, as director at Camp4 Therapeutics Corp (CAMP), director at Climb Bio, Inc. (CLYM) and EVP & President and R&D at Sana Biotechnology, Inc. (SANA) and at 2 more companies. Douglas E Williams made no open-market purchases or sales in the last 12 months. The latest filing, on June 12, 2026, reports grant or award at Camp4 Therapeutics Corp (CAMP).

Filings
20
Companies
5
Bought on market
None
Sold on market
$30.7K

Companies where Douglas E Williams is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Camp4 Therapeutics Corp logo
CAMP
Camp4 Therapeutics Corp
Directorsince March 2025$3.79Jun 12, 2026
Climb Bio, Inc. logo
CLYM
Climb Bio, Inc.
Directorsince November 2024$9.19Jun 8, 2026
Sana Biotechnology, Inc. logo
SANA
Sana Biotechnology, Inc.
EVP & President, R&Dsince April 2023$1.59Mar 8, 2024
Codiak BioSciences, Inc. logo
CDAK
Codiak BioSciences, Inc.
Officer, Director7,655$30.7KMar 30, 2023
Panacea Acquisition Corp. II logo
PANA
Panacea Acquisition Corp. II
Directorsince April 2021Apr 7, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Douglas E Williams with

Other insiders at the same companies

Questions about Douglas E Williams

What is Douglas E Williams's role at Sana Biotechnology, Inc.?
Douglas E Williams reports to the SEC as EVP & President and R&D at Sana Biotechnology, Inc. (SANA), according to the latest filing on March 8, 2024. Douglas E Williams has also filed as director at Camp4 Therapeutics Corp (CAMP), director at Climb Bio, Inc. (CLYM), officer and director at Codiak BioSciences, Inc. (CDAK) and director at Panacea Acquisition Corp. II (PANA).
How many shares does Douglas E Williams own?
After the latest filing that states it, Douglas E Williams directly owned 7,655 shares of Codiak BioSciences, Inc. (CDAK). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Douglas E Williams bought or sold stock recently?
The most recent open-market sale was on March 28, 2023: sold 41,667 shares of Codiak BioSciences, Inc. (CDAK) for $7,500 at an average of $0.18.
How do I get alerts when Douglas E Williams files?
Follow Douglas E Williams on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Douglas E Williams (SEC CIK 0001184847). Totals count each trade once, skipping amendments whose original is on file, from Jan 26, 2021 on. View on SEC EDGAR · Get this as JSON